Fawad
Butt

He spent hundreds of millions of other people's dollars adapting generic software for an industry it was never built for. Then, around 2024, Fawad Butt stopped buying and started building. The decision produced Penguin AI - a healthcare-native AI platform that, by September 2025, had convinced Greycroft, UPMC Enterprises, and Snowflake Ventures to write $29.7 million in checks.

That's the compressed version. The longer version starts with an Electronics Engineering degree and a career arc that zigzags through Sun Microsystems, TD Bank, Northern Trust, and eventually the highest floors of American healthcare - three consecutive CDO roles at organizations that, combined, touch nearly every insured American.

From Circuits to Claims

Butt's background in electronics engineering is not the obvious on-ramp to health insurance operations. But there's a certain logic to it: systems thinking, infrastructure-first design, the belief that a foundation either holds or it fails - these aren't healthcare instincts, they're engineering instincts applied to an industry that desperately needs them.

After an MBA at Northwestern's Kellogg School of Management (Product, Strategy, and Marketing - 2011 to 2013), Butt moved through senior data leadership roles at financial institutions before landing at Kaiser Permanente. At Kaiser, he built the data governance model, led enterprise-wide data privacy and security, and helped plant the infrastructure that would position Kaiser as a digital care delivery leader.

From Kaiser, the path led to UnitedHealthcare - as Chief Data and Analytics Officer, where his team served the 60 million members of UHG. Then to Optum, where he ran the entire data and analytics enterprise across three business lines, managing a multi-hundred-million-dollar P&L. At each stop, the same friction: brilliant teams, serious budgets, and technology borrowed from industries with fundamentally different constraints.

A Brief Detour Through Venture Capital

Before Penguin AI existed, Butt spent time at Canvas Ventures - a $3 billion Silicon Valley firm - as an Executive-in-Residence and Operating Partner. He evaluated healthcare investments, sat on boards as an observer, and advised portfolio companies including Particle Health, Vida Health, and PineCove Health.

He was also an early advisor to Collibra and Monte Carlo Data, two data governance startups that grew into significant companies. The pattern suggests someone who kept betting on the same thesis: good data infrastructure, properly governed, is worth more than any tool layered on top of bad data infrastructure.

The Canvas stint mattered for another reason. As an investor, Butt saw the healthcare AI market from the outside - saw what was being funded, what was being pitched, what kept failing at deployment. He came out convinced that the market needed a platform company, not another point solution. That conviction became the founding thesis for Penguin AI.

The Penguin AI Thesis

The company's founding argument is blunt: healthcare has an administrative problem worth a trillion dollars a year, the tools that exist were built for other industries, and the people who built those tools never had to use them in a clinical context. Penguin AI was built by the people who did.

The platform is designed for the back office - the dense, unglamorous machinery of prior authorizations, claims adjudication, medical coding, appeals management, risk adjustment, and payment integrity. Processes that Butt describes as not having been "reimagined in over a decade." He is not wrong. These workflows haven't changed fundamentally since the fax machine was a competitive advantage.

What distinguishes Penguin AI from the general-purpose AI tools adapted for healthcare is specificity. Butt is emphatic about this: task-specific small language models tuned for healthcare workflows outperform massive general models on clinical administrative tasks, while being faster, cheaper, and more auditable. The governance and bias correction capabilities aren't features bolted on - they're architectural choices made by someone who spent years as a Chief Data Governance Officer.

Gwen - A Name, Not an Acronym

In late 2025, Penguin AI launched Gwen - its build-your-own agentic workflow platform. The name is not an acronym. It's a digital worker you can talk to, instruct in plain language, and deploy within a clinical administrative context in about 25 minutes. The platform ships with over 100 pre-built digital workers covering HCC retrospective coding, prior authorization intake, clinical documentation summarization, and eligibility verification.

The ambition behind Gwen is larger than the product itself. Butt wants Penguin AI to become what Epic Systems became for the clinical front office - the default platform, the one that everyone eventually runs on, the standard against which alternatives are judged. He's called it publicly: "the Epic of the healthcare back office."

Philosophy: Governance Before Glamour

Butt's mental model for AI deployment runs counter to most pitch decks. He talks about data quality, governance, and infrastructure before he talks about algorithms. The thesis: you cannot automate your way out of bad data. The AI will just scale the mess.

"Without the right foundation, AI won't fix bad data; it will just make bad decisions faster." He said it in an interview, but it reads less like a sound bite and more like scar tissue - the residue of watching expensive AI deployments fail at organizations where he was responsible for the data those deployments ran on.

He's also an active voice in the Coalition for Health AI (CHAI), the industry's responsible AI workgroup, contributing specifically to standards around safety, effectiveness, equity, and transparency. For Butt, governance isn't a checkbox. It's the product.

The Change Management Problem

There's a second line from Butt that doesn't get quoted as often but cuts deeper: "People aren't afraid of new tools; they're afraid of change." It surfaces in almost every interview he gives about healthcare AI adoption. Payers and providers aren't failing to adopt AI because the technology is bad. They're failing because the change management infrastructure is absent - no clear owner, no defined ROI horizon, no organizational muscle for integrating AI into clinical workflows.

Penguin AI's pitch accounts for this. The company promises measurable ROI within months rather than years - a direct response to the reality that healthcare organizations cannot sustain multi-year transformation projects with uncertain payoffs. The out-of-the-box digital workers, the rapid deployment via Gwen, the pre-built integrations with Epic and Cerner - all of it is designed to reduce the friction between "we bought this" and "this is working."

The Funding Story

The $29.7 million Series A, led by Greycroft's $25 million check and announced in September 2025, includes a strategic dimension that matters as much as the capital. UPMC Enterprises - both investor and early partner on the Ahavi data platform - gives Penguin AI a marquee health system deployment to point to. Snowflake Ventures' participation aligns with Penguin's Snowflake-native HCC coding product, launched on Snowflake Marketplace. These aren't passive financial bets; they're ecosystem commitments.

The funding will accelerate product development, hiring, and deployments with payers and providers. With 56 employees and two years of operation, Penguin AI is still compact enough to move fast. The question now is how quickly they can convert early deployments into reference accounts that make the platform self-evident to the rest of the market.

The Trifecta No One Else Has

Most healthcare AI founders are either technologists who learned healthcare, or healthcare operators who learned technology. Butt has something rarer: he's been a buyer at scale, an investor evaluating the market, and now a builder. That trifecta shapes everything from product design to go-to-market to the questions he asks in investor meetings.

He describes himself as "the biggest buyer in healthcare." The self-awareness isn't false modesty - it's positioning. When he says Penguin AI was built by buyers, he means the team understands what the procurement side actually needs: not impressive demos, but consistent results, defensible governance, and workflows that don't require a PhD to operate.

The founding team reflects that orientation. Chief AI Officer Kishore Ayyadevara built AI capabilities generating $250 million in annual savings at UHG and holds 10 healthcare AI patents. The collective resume reads like a who's-who of healthcare technology leadership. Over 100 years of combined experience from Amazon, McKesson, Capital BlueCross, and beyond - all pointed at workflows that most technology investors still find difficult to explain at a dinner party.